Exact Mass: 446.17292960000003
Exact Mass Matches: 446.17292960000003
Found 210 metabolites which its exact mass value is equals to given mass value 446.17292960000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Thioproperazine
C22H30N4O2S2 (446.18100799999996)
Thioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihistaminic property. It is used for the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes. Overdosage may result in severe extrapyramidal symptoms with dysphagia, marked sialorrhea, persistent and rapidly increasing hyperthermia, pulmonary syndrome, state of shock with pallor and profuse sweating, which may be followed by collapse and coma. LD50 in mice is 70 mg/kg I.V., 120 mg/kg I.P., 500 mg/kg S.C. and 830 mg/kg P.O. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder[1].
Crosatoside B
Crosatoside B is isolated from the pollen of Crocus sativus (saffron). Isolated from the pollen of Crocus sativus (saffron)
phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranoside|phenethyl alcohol beta-D-(2-O-beta-D-glucopyranosyl)glucopyranoside|phenethyl beta-D-sophoroside|phenethyl O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|Phenethylalcohol 8-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside|phenylethyl-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside
4-methoxybenzyl-O-alpha-L-rhamnopyranosyl (1->6)-beta-D-glucopyranoside
4-methoxy-2,5-dimethylphenyl alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside|illoliganoside A
(1S)-1-(2-hydroxy-6-methylphenyl)ethanol 2-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside|juniperoside VII
4-hydroxyphenylethyl 4-O-beta-D-glucopyranosyl-(1->3)-O-alpha-L-rhamnopyranoside|strigoside
beta-hydroxy-phenylethyl-O-alpha-L-rhamnopyranosyl (1->6)-beta-D-glucopyranoside
2-phenylethyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|2-phenylethyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|2-phenylethyl beta-gentiobioside|phenethyl alcohol beta-D-glucopyranosyl(1- >6)-beta-D-O-glucopyranoside|phenethyl alcohol beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|phenethyl alcohol beta-gentiobioside
O-beta-D-Galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->2)-L-erythritol
C20H30O11_2-(4-Methoxyphenyl)ethyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside
C20H30O11_2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
(2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol
Thioproperazine
C22H30N4O2S2 (446.18100799999996)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder[1].
(2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol_major
Ala Asp Asn Gln
Ala Asp Gln Asn
Ala Glu Asn Asn
Ala Asn Asp Gln
Ala Asn Glu Asn
Ala Asn Asn Glu
Ala Asn Gln Asp
Ala Gln Asp Asn
Ala Gln Asn Asp
Cys Met Pro Pro
Cys Pro Met Pro
Cys Pro Pro Met
Asp Ala Asn Gln
Asp Ala Gln Asn
Asp Asp Pro Thr
C17H26N4O10 (446.16488560000005)
Asp Asp Thr Pro
C17H26N4O10 (446.16488560000005)
Asp Glu Pro Ser
C17H26N4O10 (446.16488560000005)
Asp Glu Ser Pro
C17H26N4O10 (446.16488560000005)
Asp Gly Gln Gln
Asp Asn Ala Gln
Asp Asn Gln Ala
Asp Pro Asp Thr
C17H26N4O10 (446.16488560000005)
Asp Pro Glu Ser
C17H26N4O10 (446.16488560000005)
Asp Pro Ser Glu
C17H26N4O10 (446.16488560000005)
Asp Pro Thr Asp
C17H26N4O10 (446.16488560000005)
Asp Gln Ala Asn
Asp Gln Gly Gln
Asp Gln Asn Ala
Asp Gln Gln Gly
Asp Ser Glu Pro
C17H26N4O10 (446.16488560000005)
Asp Ser Pro Glu
C17H26N4O10 (446.16488560000005)
Asp Thr Asp Pro
C17H26N4O10 (446.16488560000005)
Asp Thr Pro Asp
C17H26N4O10 (446.16488560000005)
Glu Ala Asn Asn
Glu Asp Pro Ser
C17H26N4O10 (446.16488560000005)
Glu Asp Ser Pro
C17H26N4O10 (446.16488560000005)
Glu Gly Asn Gln
Glu Gly Gln Asn
Glu Asn Ala Asn
Glu Asn Gly Gln
Glu Asn Asn Ala
Glu Asn Gln Gly
Glu Pro Asp Ser
C17H26N4O10 (446.16488560000005)
Glu Pro Ser Asp
C17H26N4O10 (446.16488560000005)
Glu Gln Gly Asn
Glu Gln Asn Gly
Glu Ser Asp Pro
C17H26N4O10 (446.16488560000005)
Glu Ser Pro Asp
C17H26N4O10 (446.16488560000005)
Gly Asp Gln Gln
Gly Glu Asn Gln
Gly Glu Gln Asn
Gly Asn Glu Gln
Gly Asn Gln Glu
Gly Gln Asp Gln
Gly Gln Glu Asn
Gly Gln Asn Glu
Gly Gln Gln Asp
Met Cys Pro Pro
Met Pro Cys Pro
Met Pro Pro Cys
Asn Ala Asp Gln
Asn Ala Glu Asn
Asn Ala Asn Glu
Asn Ala Gln Asp
Asn Asp Ala Gln
Asn Asp Gln Ala
Asn Glu Ala Asn
Asn Glu Gly Gln
Asn Glu Asn Ala
Asn Glu Gln Gly
Asn Gly Glu Gln
Asn Gly Gln Glu
Asn Asn Ala Glu
Asn Asn Glu Ala
Asn Gln Ala Asp
Asn Gln Asp Ala
Asn Gln Glu Gly
Asn Gln Gly Glu
Pro Cys Met Pro
Pro Cys Pro Met
Pro Asp Asp Thr
C17H26N4O10 (446.16488560000005)
Pro Asp Glu Ser
C17H26N4O10 (446.16488560000005)
Pro Asp Ser Glu
C17H26N4O10 (446.16488560000005)
Pro Asp Thr Asp
C17H26N4O10 (446.16488560000005)
Pro Glu Asp Ser
C17H26N4O10 (446.16488560000005)
Pro Glu Ser Asp
C17H26N4O10 (446.16488560000005)
Pro Met Cys Pro
Pro Met Pro Cys
Pro Pro Cys Met
Pro Pro Met Cys
Pro Ser Asp Glu
C17H26N4O10 (446.16488560000005)
Pro Ser Glu Asp
C17H26N4O10 (446.16488560000005)
Pro Thr Asp Asp
C17H26N4O10 (446.16488560000005)
Gln Ala Asp Asn
Gln Ala Asn Asp
Gln Asp Ala Asn
Gln Asp Gly Gln
Gln Asp Asn Ala
Gln Asp Gln Gly
Gln Glu Gly Asn
Gln Glu Asn Gly
Gln Gly Asp Gln
Gln Gly Glu Asn
Gln Gly Asn Glu
Gln Gly Gln Asp
Gln Asn Ala Asp
Gln Asn Asp Ala
Gln Asn Glu Gly
Gln Asn Gly Glu
Gln Gln Asp Gly
Gln Gln Gly Asp
Ser Asp Glu Pro
C17H26N4O10 (446.16488560000005)
Ser Asp Pro Glu
C17H26N4O10 (446.16488560000005)
Ser Glu Asp Pro
C17H26N4O10 (446.16488560000005)
Ser Glu Pro Asp
C17H26N4O10 (446.16488560000005)
Ser Pro Asp Glu
C17H26N4O10 (446.16488560000005)
Ser Pro Glu Asp
C17H26N4O10 (446.16488560000005)
Thr Asp Asp Pro
C17H26N4O10 (446.16488560000005)
Thr Asp Pro Asp
C17H26N4O10 (446.16488560000005)
Thr Pro Asp Asp
C17H26N4O10 (446.16488560000005)
Crosatoside B
A glycosylglucose derivative that is alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose in which the anomeric hydroxy hydrogen has been replaced by a 2-(4-hydroxyphenyl)ethyl group.
Ethyl 18-bromo-8E,17E19Z-tricosatrien-4,6-diynoate
2-(4-Methoxyphenyl)ethyl 6-O-?-L-arabinopyranosyl-?-D-glucopyranoside
Ethyl 18-bromo-8E,17E,19Z-tricosatrien-4,6-diynoate
3-[[4-[benzylethylamino]phenyl]azo]-1,2-dimethyl-1H-1,2,4-triazolium methyl sulphate
C20H26N6O4S (446.17361560000006)
Fmoc-L-Homoarginine Hydrochloride Salt
C22H27ClN4O4 (446.17207320000006)
Cvt-6883
GS-6201 (CVT-6883) is a selective adenosine A2B receptor antagonist. GS-6201 displays high affinity and selectivity for the human adenosine A2B receptors (Ki=22 nM)[1]. GS-6201 reduces caspase-1 activity in the heart, and attenuates cardiac remodeling after acute myocardial infarction (AMI) in the mouse[2]. GS-62013 attenuates the airway reactivity induced by NECA, AMP, or allergen in sensitized mice[3].
N-(Deoxyguanosin-8-yl)-2-aminofluorene
D009676 - Noxae > D002273 - Carcinogens
3-benzyl-4-methyl-7-[(3,4,5-trimethoxybenzyl)oxy]-2H-chromen-2-one
(2S,4R)-1-Acetyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-benzothiazolylcarbonyl)butyl]-4-hydroxy-2-pyrrolidinecarboxamide
C20H26N6O4S (446.17361560000006)
2-[2-(4-Methoxyphenyl)ethoxy]-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxane-3,4,5-triol
2-(4-methoxyphenyl)ethyl 6-O-a-L-arabinopyranosyl-b-D-glucopyranoside
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(3-phenylmethoxyphenyl)methylideneamino]-5-propan-2-yltriazole-4-carboxamide
N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide
1-[3-[(E)-2-cyano-3-(furan-2-ylmethylamino)-3-oxoprop-1-enyl]-4-oxopyrido[1,2-a]pyrimidin-2-yl]piperidine-4-carboxamide
2-[[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-methylamino]-N-[2-(4-morpholinyl)phenyl]acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5R,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2R,5S,6R)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5S,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5S,6R)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5R,6R)-5-[(4-chlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-pyridin-2-ylacetamide
C22H27ClN4O4 (446.17207320000006)
[(1S,2aR,8bR)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
[(1R,2aR,8bR)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
N-[2-[(2R,5R,6R)-5-[(4-chlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-pyridin-2-ylacetamide
C22H27ClN4O4 (446.17207320000006)
(2R)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
N-[2-[(2R,5R,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
[(1R,2aS,8bS)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
(6R,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7R,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(2R)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
N-[2-[(2R,5S,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)